Natera

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

BillionToOne

This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.

CytoTerra

This company develops next-generation sequencing assays to detect chromosomal abnormalities for clinical researchers and healthcare providers specialising in oncology and genetic diseases.

Adela

The company develops blood-based genomic tests for early cancer detection and minimal residual disease monitoring for healthcare providers and biopharmaceutical partners.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

NX Pharmagen

This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.

Xgenera

Xgenera develops a multi-cancer early detection blood test to help clinicians and patients identify multiple cancer types at their earliest stages.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.